Affordable Access

An Indocyanine Green-Based Nanoprobe for In Vivo Detection of Cellular Senescence.

Authors
  • Baker, Andrew G
  • Hartono, Muhamad
  • Ou, Hui-Ling
  • Popov, Andrea Bistrović
  • Brown, Emma L
  • Joseph, James
  • Golinska, Monika
  • González-Gualda, Estela
  • Macias, David
  • Ge, Jianfeng
  • Denholm, Mary
  • Morsli, Samir
  • Sanghera, Chandan
  • Else, Thomas R
  • Greer, Heather F
  • Vernet, Aude
  • Bohndiek, Sarah E
  • Muñoz-Espín, Daniel
  • Fruk, Ljiljana
Publication Date
Mar 12, 2024
Source
Apollo - University of Cambridge Repository
Keywords
Language
English
License
Green
External links

Abstract

Publication status: Published / There is an urgent need to improve conventional cancer-treatments by preventing detrimental side effects, cancer recurrence and metastases. Recent studies have shown that presence of senescent cells in tissues treated with chemo- or radiotherapy can be used to predict the effectiveness of cancer treatment. However, although the accumulation of senescent cells is one of the hallmarks of cancer, surprisingly little progress has been made in development of strategies for their detection in vivo. To address a lack of detection tools, we developed a biocompatible, injectable organic nanoprobe (NanoJagg), which is selectively taken up by senescent cells and accumulates in the lysosomes. The NanoJagg probe is obtained by self-assembly of indocyanine green (ICG) dimers using a scalable manufacturing process and characterized by a unique spectral signature suitable for both photoacoustic tomography (PAT) and fluorescence imaging. In vitro, ex vivo and in vivo studies all indicate that NanoJaggs are a clinically translatable probe for detection of senescence and their PAT signal makes them suitable for longitudinal monitoring of the senescence burden in solid tumors after chemotherapy or radiotherapy.

Report this publication

Statistics

Seen <100 times